Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

Neuron

Volumn 13, Issue 4, 1994, Pages 1017-1030

  Martinou, Jean Claude ^a   Dubois Dauphin, Michel ^b   Staple, Julie K ^a   Rodriguez, Ivan ^b   Frankowski, Harald ^a   Missotten, Marc ^a   Albertini, Paola ^c   Talabot, Dominique ^a   Catsicas, Stefan ^a   Pietra, Claudio ^c   Huarte, Joaquin ^b  

^a GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; NEURON SPECIFIC ENOLASE; PHOSPHOGLYCERATE KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL COUNT; CELL DEATH; CELL SURVIVAL; ENZYME REGULATION; FACIAL NERVE NUCLEUS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; RETINA GANGLION CELL; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CELL DEATH; FACIAL NERVE; GANGLIA, SPINAL; GENE EXPRESSION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NEURONS; OPTIC NERVE; PHOSPHOGLYCERATE KINASE; PHOSPHOPYRUVATE HYDRATASE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 0027944004     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0896-6273(94)90266-6     Document Type: Article

References (73)

1. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter
2. Neuronal and glial cell responses to axon injury
3. The proto-oncogene bcl-2 can selectively rescue neutrophic factor-dependent neurons from apoptosis
4. Gonadal steroid induction of structural sex differences in the central nervous system
5. The development of facial motoneurons in the mouse: neuronal death and the innervation of the facial muscle cells
6. H on chromosome 14 and near a transcriptional unit on 18
7. Trophic factors and neuronal survival
8. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
9. Peripheral neuropathy in mouse hereditary diabetes mellitus. II. Ultrastructural correlates of degenerative and regenerative changes
10. Spatiotemporal gradients of kainate-sensitivity in the developing chicken retina
11. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia
12. Megamitochondria in hepatic and renal disease
13. Single-step method of isolation by acid guanidinium thiocyanate-chloroform extraction
14. Neuronal death in the development of the vertebrate nervous system
15. Developmental cell death: morphological diversity and multiple mechanisms
16. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglob-ulin transcript resulting from the t(14;18) translocation
17. Neuronal death as a regulative mechanism in the control of cell number in the nervous system
18. Naturally occuring neuron death and its regulation by developing neural pathways
19. Testosterone propionate administration prevents the loss of neurons within the central part of the medial preoptic nucleus
20. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death.
21. Mechanisms and functions of cell death
22. Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control
23. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene
24. CELL DEATHS IN NORMAL VERTEBRATE ONTOGENY
25. C. elegans gene ced-9 protects cells from programmed cell death
26. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
27. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
28. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
29. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA
30. Molecular mechanisms of developmental neuronal death
31. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
32. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase
33. Bcl-2: a repressor of lymphocyte death
34. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2
35. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis
36. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to Bcl-2
37. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury.
38. The protooncogene bcl-2 inhibits apoptosis in PC12 cells
39. Imperforate vagina in mice: per cent incidence and surgical repair
40. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS
41. Ultrastructural localization of BCL-2 protein
42. Histologic and histochemical study of motor neurons with special reference to experimental degeneration, aging and drug actions
43. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoetic cell lines
44. Cell death during development of the nervous system
45. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death
46. Timing of paternal Pgk-1 expression in embryos of transgenic mice
47. Transcriptional interference and termination between duplicated-a-globin gene constructs suggests a novel mechanism for gene regulation
48. Neuronal competition
49. Social controls on cell survival and death: an extreme view
50. Programmed cell death and the control of cell survival: lessons from the nervous system
51. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo
52. Cellular mechanisms of disease series. Bcl-2 and the regulation of programmed cell death
53. Genomic imprinting determines methylation of parental alleles in transgenic mice
54. Degree of methylation of transgenes is dependent on a gamete of origin
55. Localization of neuron-specific enolase (NSE) mRNA in human brain
56. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
57. Inhibition of thymocyte apoptosis and negative antigenic selection in Bcl-2 transgenic mice
58. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
59. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a Bcl-2 transgene
60. Age differences in response to chronic hypoxia on the fine structure of cardiac muscle and automatic ganglion cells
61. Laterality associated with sexual dimorphism in the volume of the mouse hypogastric ganglion
62. Cloning of the chromosommc breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
63. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
64. Bcl-2-deficient mice demonstrate fullminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
65. Synapse formation is related to the onset of neuronspecific enolase immunoreactivity in the avian auditory and vestibular system
66. Molecular regulation of apoptosis: genetic controls on cell death
67. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum
68. Human Copper-Zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischernia
69. Androgens-induced atresia of the vagina in Sprague-Dawley female rats
70. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death
71. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death
72. The C. elegans cell death gene ced-3 encodes a protein similarto mammalian interleukin-1(3-converting enzyme
73. Bcl-2 and neuronal selection during development of the nervous system